Gm. Kline et al., TOLERANCE TO EXPERIMENTAL CARDIAC ALLOGRAFTS PRODUCED BY NEONATAL INTRATHYMIC INJECTION OF DONOR CELLS, The Annals of thoracic surgery, 58(5), 1994, pp. 1316-1318
Intrathymic inoculation of allogeneic cells after systemic administrat
ion of antilymphocyte serum in adult experimental animals has produced
donor-specific tolerance to cardiac allografts. We investigated wheth
er thymic injection of allogeneic cells without antilymphocyte serum i
n neonatal Lewis rats (day 1 of life) with immature immune systems als
o produced tolerance to cardiac grafts. Intrathymic or intraperitoneal
injection of 5 x 10(7) Lewis (control) or Lewis-Brown Norway (allogen
eic) spleen cells in Lewis neonates was followed by heterotopic cardia
c transplantation using Lewis, Lewis-Brown Norway, or Wistar Furth (th
ird-party allograft) hearts at 6 to 8 weeks of age. Graft survival was
prolonged with both intraperitoneal and intrathymic allogeneic cells.
Recipients of cells by the intrathymic route had longer graft surviva
l, and 2 of 5 animals achieved permanent graft acceptance (longer than
100 days). As expected, Lewis isografts survived indefinitely, wherea
s third-party Wistar Furth allografts were rejected in the usual time
frame. Intrathymic introduction of allogeneic cells in a neonatal reci
pient with an immature immune system can produce donor-specific tolera
nce to a subsequent graft without the need for a systemic immunosuppre
ssion regimen, even transiently